This site is intended for health professionals only

Study hope for early ejaculation

A new study has shown men suffering from premature ejaculation can be treated with a drug in tablet form, the first to be developed to ease the problem.

The data, presented for the first time at the European Association of Urology, show that men with premature ejaculation (PE) can be treated with the drug dapoxetine.

A multinational clinical trial recruited over 1,000 men and their female partners from 22 countries to measure the improvement of men’s sexual functioning while taking the drug.

The study also looked at the satisfaction of the women involved by asking them about their experience while their partner was taking the drug.

Article continues below this sponsored advert
Cogora InRead Image
Join us at a one-day virtual cardiology event that will allow you to explore the latest advances in cardiovascular care. With the help of an advisory board of cardiology specialists we have put together an agenda tailored to multi-disciplinary teams - each talk is presented by an expert, or panel, who will share knowledge and case studies of relevance

Results from them show a significant improvement in the four categories they were asked about: their perception of how much control the man had over ejaculation; their distress at the timing of it; their satisfaction with intercourse and any social awkwardness caused by ejaculation.

The findings confirm the results of a separate study into how PE affects female partners, which confirmed it had significant impact in those areas.

Professor Jacques Buvat, Director of the Centre d’Etude et de Traitement de la Pathologie de l’Appareil Reproducteur et de la Psychosomatique in France, who led the trial, said: “Dapoxetine has been shown to help men and their partners experience greater sexual satisfaction, and reduce interpersonal distress.”

Copyright © PA Business 2008

European Association of Urology

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine